Searchable abstracts of presentations at key conferences in endocrinology

ea0081p92 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Transforming growth factor beta 1: a new factor reducing hepatic sex hormone binding globulin production during liver fibrosis development

Brianso Llort Laura , Fuertes Rioja Lidia , Ramos Perez Lorena , Salcedo Allende Maria Teresa , Hernandez Cristina , Canonge Rafael Simo , Martinez David

Low plasma sex hormone-binding globulin (SHBG) levels are present in fatty liver disease, which represent a spectrum of diseases ranging from hepatocellular steatosis through steatohepatitis to fibrosis and irreversible cirrhosis. We have previously determined that fat accumulation reduces SHBG production in different non-alcoholic fatty liver disease (NAFLD) mouse models and that SHBG plays an active role in the development of this disease. In the present work, we are interes...

ea0073aep490 | Pituitary and Neuroendocrinology | ECE2021

Third month MRI predicts macroprolactinoma reduction after cabergoline therapy

Biagetti Betina , Sarria-Estrada Silvana , Ng-Won Karelis , Martinez-Saez Elena , Casteras Anna , Cordero-Asanza Esteban , Irene Hernández-Hernández , Efrain Cordero-Vazquez. , Alba Rojano , Canonge Rafael Simo

BackgroundTranssphenoidal surgery is in general the preferred first-line treatment for patients with macroadenomas except for prolactinomas, which is mainly indicated when the treatment with dopamine agonists (DA) fails. However, in those patients resistant to DA (i.e. volume reduction ObjectiveTo identify predictors of DA resistance in order...